文献速递细菌感染、耐药与抗菌药物医院感染防控

新型抗生素在产KPC肺炎克雷伯菌感染中的作用

Role of new antibiotics for KPC-producing Klebsiella pneumoniae.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

本文综述了针对产KPC肺炎克雷伯菌的新型抗生素,包括β-内酰胺酶抑制剂复方(头孢他啶/阿维巴坦、美罗培南/伐博巴坦、亚胺培南/瑞来巴坦)、头孢菌素-铁载体偶联物头孢地尔、氨基糖苷衍生物普拉佐米星和四环素衍生物依拉环素。这些药物针对碳青霉烯耐药肠杆菌目,但存在类内交叉耐药和关键缺口,需快速分子诊断和严格抗菌药物管理以保持疗效。

要点

  • 新型BLI复方和头孢地尔等对产KPC菌有效,但需注意交叉耐药。
  • 快速分子诊断和抗菌药物管理对保持新药疗效至关重要。
  • 产KPC菌耐药机制多样,治疗选择仍有限。

核心结论

  • 新型抗生素为产KPC肺炎克雷伯菌感染提供选择,但需管理以保持疗效。

研究设计与样本

  • 综述,总结新型抗生素在产KPC肺炎克雷伯菌中的作用。

主要发现

  • β-内酰胺酶抑制剂复方、头孢地尔、普拉佐米星和依拉环素等新药针对碳青霉烯耐药肠杆菌目。
  • 这些药物存在类内交叉耐药和关键治疗缺口。

临床怎么用

  • 使用新型抗生素需结合快速分子诊断和严格抗菌药物管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Klebsiella pneumoniae has accumulated a wide range of resistance determinants and has evolved into a difficult-to-treat pathogen that poses an increasing healthcare threat. KPC is an important marker for extensively drug-resistant (XDR) organisms with limited treatment options. In response to the medical need for new treatment options, several new antibiotics have been developed and registered recently. The β-lactamase inhibitor (BLI) combinations ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam, the cephalosporin-siderophore conjugate cefiderocol, the aminoglycoside derivative plazomicin and the tetracycline derivative eravacycline, focus on carbapenem-resistant Enterobacterales. These modified agents from old antibiotic classes illustrate the challenges of this requirement to address class-specific resistance mechanisms while critical gaps and some cross-resistance within a class, or to unrelated antibiotic classes, remain. The diverse molecular mechanisms and increasing diversification of carbapenem resistance among Klebsiella isolates requires improved rapid molecular diagnostic capabilities and stringent stewardship programmes to preserve the efficacy of new antibiotics for as long as possible.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Theuretzbacher U, Carrara E, Conti M, et al. Role of new antibiotics for KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2021. PMID: 33534882. doi:10.1093/jac/dkaa497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。